CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Sean McCarthy will participate on a panel at the Charlotte Biotechnology Conference titled "Financing Successful Biotech Companies", on the campus of UNC-Charlotte.
News | 10. 12. 2007
